Kowalski A, Nowak P, Schröder R. "一种阿布昔替尼杂质12的合成方法" [P]. European Patent, EP 3910752 A1, 2019-07-11.
Roberts E F, Anderson J P, Schröder R. "Method for the Synthesis of Abrocitinib Impurity 12" [P]. US Patent, US 9400929 B2, 2020-05-16.
发明人朱建伟,刘建华,钱学锋. "A Process for Preparing High-Purity Abrocitinib Impurity 12" [P]. 中国发明专利, 专利号 CN 111535934 B, 授权公告日 2016-07-25.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 阿布昔替尼杂质12 in Pharmaceutical Formulations". J. Agric. Food Chem., 2014, 1435, 8952-8958.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿布昔替尼杂质12 as an Impurity". J. Nat. Prod., 2014, 2060, 4142-4158.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Abrocitinib Impurity 12 Using HRMS and NMR". J. Chromatogr. A, 2023, 2077, (10), 188-198.